Gut microbiome research has become essential to almost every medical research field. Next-generation sequencing (NGS) technologies have been crucial in enabling a breakthrough in our understanding of the significant role gut microbes play in health and disease. However, the field is now moving past the exploratory research phase and there is a need to translate microbiome research findings into actionable clinical solutions. 

Application of NGS for this purpose faces several challenges related to precision, turnaround time, cost per sample, and the need for complex bioinformatic pipelines. Our mission is to provide researchers and industry with a qPCR-based analysis service that delivers actionable microbiome results. 

Bio-Me team consists of highly competent scientists with long experience in the microbiome and life technology sector, covering all the skill-sets necessary for a fully functional and integrated team.

We enjoy working together and are motivated to make a difference in the health care industry through our unique approach and technology. Learn more about our team.

Bio-Me is setting the standard for next generation routine microbiome analysis with our Precision Microbiome Profiling (PMP™) platform.

We enable rapid, accurate and highly reproducible microbiome analysis solutions down to the strain level thanks to our high-throughput qPCR-based platform. We tailor solutions to your specific needs and area of interest. Learn more about our technology or our solutions.